These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Joshi PB, Kelly BL, Kamhawi S, Sacks DL, McMaster WR. Mol Biochem Parasitol; 2002 Mar; 120(1):33-40. PubMed ID: 11849703 [Abstract] [Full Text] [Related]
3. Transmission blocking vaccine studies in leishmaniasis: I. Lipophosphoglycan is a promising transmission blocking vaccine molecule against cutaneous leishmaniasis. Tonui WK, Mbati PA, Anjili CO, Orago AS, Turco SJ, Githure JI, Koech DK. East Afr Med J; 2001 Feb; 78(2):84-9. PubMed ID: 11682952 [Abstract] [Full Text] [Related]
4. In vitro infectivity and differential gene expression of Leishmania infantum metacyclic promastigotes: negative selection with peanut agglutinin in culture versus isolation from the stomodeal valve of Phlebotomus perniciosus. Alcolea PJ, Alonso A, Degayón MA, Moreno-Paz M, Jiménez M, Molina R, Larraga V. BMC Genomics; 2016 May 20; 17():375. PubMed ID: 27206922 [Abstract] [Full Text] [Related]
5. Differentially expressed Leishmania major gp63 genes encode cell surface leishmanolysin with distinct signals for glycosylphosphatidylinositol attachment. Voth BR, Kelly BL, Joshi PB, Ivens AC, McMaster WR. Mol Biochem Parasitol; 1998 May 15; 93(1):31-41. PubMed ID: 9662026 [Abstract] [Full Text] [Related]
6. The Transcriptome of Leishmania major Developmental Stages in Their Natural Sand Fly Vector. Inbar E, Hughitt VK, Dillon LA, Ghosh K, El-Sayed NM, Sacks DL. mBio; 2017 Apr 04; 8(2):. PubMed ID: 28377524 [Abstract] [Full Text] [Related]
12. Expression of LPG and GP63 by different developmental stages of Leishmania major in the sandfly Phlebotomus papatasi. Davies CR, Cooper AM, Peacock C, Lane RP, Blackwell JM. Parasitology; 1990 Dec 04; 101 Pt 3():337-43. PubMed ID: 2092290 [Abstract] [Full Text] [Related]
13. Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection. Rivier D, Bovay P, Shah R, Didisheim S, Mauël J. Parasite Immunol; 1999 Sep 04; 21(9):461-73. PubMed ID: 10476055 [Abstract] [Full Text] [Related]
14. Influence of parasite encoded inhibitors of serine peptidases in early infection of macrophages with Leishmania major. Eschenlauer SC, Faria MS, Morrison LS, Bland N, Ribeiro-Gomes FL, DosReis GA, Coombs GH, Lima AP, Mottram JC. Cell Microbiol; 2009 Jan 04; 11(1):106-20. PubMed ID: 19016791 [Abstract] [Full Text] [Related]
15. Expression of the major surface glycoprotein of Leishmania, gp63, in wild-type and sinefungin-resistant promastigotes. Soteriadou KP, Tzinia AK, Mamalaki A, Phelouzat MA, Lawrence F, Robert-Gero M. Eur J Biochem; 1994 Jul 01; 223(1):61-8. PubMed ID: 8033909 [Abstract] [Full Text] [Related]
17. Evaluation of expression variations in virulence-related genes of Leishmania major after several culture passages compared with Phlebotomus papatasi isolated promastigotes. Nemati Haravani T, Parvizi P, Hejazi SH, Sedaghat MM, Eskandarian A, Nateghi Rostami M. PLoS One; 2023 Jul 01; 18(4):e0284240. PubMed ID: 37053214 [Abstract] [Full Text] [Related]